Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 448 of 1,261
  1. US 10537528

    Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine compounds

    The Regents of the University of California · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted
  2. US 10538763

    Compounds and methods for modulation of DUX4

    Ionis Pharmaceuticals, Inc. · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted
  3. WO 2020012244

    TRAITEMENT DE LA RECTOCOLITE HÉMORRAGIQUE AU MOYEN DE BRAZIKUMAB

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Jan 16, 2020 · Expires Jan 11, 2040

    granted
  4. US 2020017529

    NOVEL THIENOTHIOPHENE COMPOUNDS FOR LONG-ACTING INJECTABLE COMPOSITIONS AND RELATED METHODS

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Jan 16, 2020 · Expires Jan 11, 2040

    granted
  5. US 2020016151

    NOVEL NAPHTHYLENYL COMPOUNDS FOR LONG-ACTING INJECTABLE COMPOSITIONS AND RELATED METHODS

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Jan 16, 2020 · Expires Jan 11, 2040

    granted
  6. US 10533053

    Nucleic acids encoding activatable antibodies that bind epidermal growth factor receptor

    CytomX Therapeutics, Inc. · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  7. US 10532096

    Methods and compositions comprising a combination of a VEGF antagonist and an anti-CTLA-4 antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  8. US 10531680

    Creatine ester pronutrient compounds and formulations

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  9. US 10532101

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  10. US 10532050

    Formulations of oxabicycloheptanes and oxabicycloheptenes

    Lixte Biotechnology, Inc. · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  11. US 10533174

    Splice-region antisense composition and method

    Sarepta Therapeutics, Inc. · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  12. US 10532032

    Rolled collagen carrier

    TAKEDA AS · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  13. US 10533997

    Reverse genetics system of Zika virus

    The Board of Regents of the University of Texas System · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  14. US 10533190

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  15. US 10533186

    Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof

    The Board of Regents of the University of Texas System · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  16. US 10533175

    Compositions and methods for modulating Ataxin 3 expression

    Ionis Pharmaceuticals, Inc. · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  17. US 10533171

    Oligonucleotide comprising an inosine for treating DMD

    BIOMARIN TECHNOLOGIES B.V. · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  18. US 10533056

    Macropinocytosing human anti-CD46 antibodies and targeted cancer therapeutics

    The Regents of the University of California · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  19. US 10533016

    Compounds that participate in cooperative binding and uses thereof

    Revolution Medicines, Inc. · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  20. US 10532022

    Whole stablized olive mill process water, production thereof and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  21. US 10531654

    Methods and compositions for vein harvest and autografting

    United States Government as represented by the Department of Veterans Affairs · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  22. US 10533159

    Pichinde virus reverse genetics systems and methods of use

    Regents of the University of Minnesota · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  23. US 10533040

    Colon and pancreas cancer peptidomimetics

    PRECISION BIOLOGICS, INC. · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  24. US 10532992

    Prodrugs of urolithins and uses thereof

    Amazentis SA · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.